Our strength lies in our people. Our core team consists of individuals with profound experience and unmatched intellectual ability in their respective areas. We are a team of dedicated and motivated individuals, who integrate well to form multifunctional teams and provide uncompromising commitment to quality, cost effectiveness and efficiency in our services.

  COO, Doctorate in Cancer Biology from National Institute of Immunology and a post graduate in Pharmaceutical Science (Gold Medalist); Dr. Jaggi is a seasoned scientific leader bringing over 20 years of successfully leading discovery research and advanced preclinical drug development teams with special focus in global collaborative drug discovery research.
He holds over 100 patents and led a successful discovery team which resulted in a first-in-world clinical candidate, polymeric Nanoparticle based drug delivery system.
Dr. Jaggi has published and presented over 40 research papers in peer-reviewed journals. He holds memberships in several scientific committees and has attended and presented at several international and Indian conferences and meetings.
  CSO, Doctorate in Tumor Biology from All India Institute of Medical Science, and post postdoctoral research in signal transduction alterations in adenocarcinomas at National Institute of Immunology; Dr. Anu is a seasoned scientific leader with over 20 years of comprehensive experience in new drug discovery and early preclinical drug development and scientific operations with special interest in translatory research of photochemical based products.
Dr. Anu was instrumental in discovery and development of first-in-world clinical candidate, polymeric Nanoparticle based drug delivery system.
Anu holds over 14 US Patents and more than 46 in rest of the world and several more in India. She has published and presented more than 30 research papers in peer-reviewed journals & scientific meetings.
  Adviser, Ex-Director, of Institute of Pathology (ICMR), Dr. Mukherjee brings more than 35 years of extensive experience in human and animal pathology especially focused toward accelerating early drug discovery and preclinical development.
Dr. Mukherjee provides oversight and leads a team of pathologist providing histopathological insight and correlating findings with investigational product. He also advises on primary scientific resource for all toxicological pathology activities in support of the various areas within Dabur Research Foundation. Dr. Mukherjee has carried out extensive research in communicable diseases. He has been associated with DRF since 1999

Back to top